{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:28:29Z","timestamp":1788449309616,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ygyno.2022.09.014","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T22:52:12Z","timestamp":1663887132000},"page":"174-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The contemporary presentation and diagnosis of endometrial cancer recurrence: When, where, and how?"],"prefix":"10.1016","volume":"167","author":[{"given":"Courtney J.","family":"Riedinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna M.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floor J.","family":"Backes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin L.","family":"Bixel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry J.","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Goodfellow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey M.","family":"Cosgrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2022.09.014_bb0005","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2022.09.014_bb0010","series-title":"Cancer Survival Among Adults: US SEER Program, 1988\u20132001, Patient and Tumor Characteristics. SEER Survival Monograph","article-title":"Cancer of the cervix uteri","author":"Kosary","year":"2007"},{"issue":"3","key":"10.1016\/j.ygyno.2022.09.014_bb0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/AOG.0000000000004676","article-title":"The changing landscape of gynecologic cancer mortality in the United States","volume":"139","author":"Giaquinto","year":"2022","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2022.09.014_bb0020","series-title":"SEER Cancer Statistics Review, 1975\u20132018","year":"2021"},{"issue":"3","key":"10.1016\/j.ygyno.2022.09.014_bb0025","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2006.02.011","article-title":"Follow-up after primary therapy for endometrial cancer: a systematic review","volume":"101","author":"Fung-Kee-Fung","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.09.014_bb0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ygyno.2011.07.014","article-title":"Recurrence patterns and surveillance for patients with early stage endometrial cancer","volume":"123","author":"Salani","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"9213","key":"10.1016\/j.ygyno.2022.09.014_bb0035","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ygyno.2022.09.014_bb0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/ijgc-2019-000822","article-title":"Clinical outcome of recurrent endometrial cancer: analysis of post-relapse survival by pattern of recurrence and secondary treatment","volume":"30","author":"Legge","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2022.09.014_bb0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2019.04.676","article-title":"Recurrent early stage endometrial cancer: patterns of recurrence and results of salvage therapy","volume":"154","author":"Francis","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2022.09.014_bb0050","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/onco.13934","article-title":"Endometrial cancer: who lives, who dies, can we improve their story?","volume":"26","author":"Cosgrove","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.ygyno.2022.09.014_bb0055","first-page":"459","article-title":"Chemotherapy in endometrial cancer","volume":"4","author":"Obel","year":"2006","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"10.1016\/j.ygyno.2022.09.014_bb0060","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.18.01575","article-title":"Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel\/carboplatin in high-intermediate and high risk early stage endometrial cancer","volume":"37","author":"Randall","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2022.09.014_bb0065","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1470-2045(19)30395-X","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high risk endometrial cancer (PORTEC-3): patterns of recurrence and post hoc survival analysis of a randomized phase 3 trial","volume":"20","author":"de Boer","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2022.09.014_bb0070","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa1813181","article-title":"Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer","volume":"380","author":"Matei","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2022.09.014_bb0075","series-title":"Uterine Neoplasms Version 1.2021. Plymouth Meeting","author":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)","year":"2022"},{"issue":"3","key":"10.1016\/j.ygyno.2022.09.014_bb0080","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ygyno.2018.12.010","article-title":"Evolving trends in the management of high-intermediate risk endometrial cancer in the United States","volume":"152","author":"Zakem","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.09.014_bb0085","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1016\/j.ygyno.2007.07.025","article-title":"Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients","volume":"107","author":"Sartori","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.09.014_bb0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/gyno.1995.1262","article-title":"Postsurgical surveillance of patients with FIGO stage I\/II endometrial adenocarcinoma","volume":"59","author":"Berchuck","year":"1995","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.09.014_bb0095","series-title":"Five Things Physicians and Patients Should Question","author":"Society of Gynecologic Oncology","year":"2021"},{"key":"10.1016\/j.ygyno.2022.09.014_bb0100","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.22.00471","article-title":"Effectiveness of intensive versus minimalist follow-up regimen on survival in patients with endometrial cancer (TOTEM study): a randomized, pragmatic, parallel group, multicenter trial","author":"Zola","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2022.09.014_bb0105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2022.09.014_bb0110","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/ijgc-00009577-200409000-00029","article-title":"The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients","volume":"14","author":"Tjalma","year":"2004","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2022.09.014_bb0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejca.2016.09.033","article-title":"The nature of early-stage endometrial cancer recurrence\u2014a national cohort study","volume":"69","author":"Jeppesen","year":"2016","journal-title":"Eur. J. Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2022.09.014_bb0120","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1471-0528.1996.tb09843.x","article-title":"Is there any value in the long term follow up of women treated for endometrial cancer?","volume":"103","author":"Owen","year":"1996","journal-title":"BJOG"},{"issue":"3B","key":"10.1016\/j.ygyno.2022.09.014_bb0125","first-page":"1977","article-title":"An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer","volume":"20","author":"Gadducci","year":"2000","journal-title":"Anticancer Res."},{"issue":"7","key":"10.1016\/j.ygyno.2022.09.014_bb0130","first-page":"879","article-title":"Costs and benefits of routine follow-up after curative treatment for endometrial cancer","volume":"157","author":"Agboola","year":"1997","journal-title":"CMAJ"},{"issue":"1994","key":"10.1016\/j.ygyno.2022.09.014_bb0135","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/gyno.1994.1282","article-title":"An evaluation of routine follow-up of patients treated for endometrial carcinoma","volume":"55","author":"Shumsky","year":"1994","journal-title":"Gynecol. Oncol."},{"issue":"21","key":"10.1016\/j.ygyno.2022.09.014_bb0140","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006920","article-title":"Stratification of risk groups according to survival after recurrence in endometrial cancer patients","volume":"96","author":"Shim","year":"2017","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.ygyno.2022.09.014_bb0145","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12885-018-4313-x","article-title":"Gynecologic cancer survivor preferences for long-term surveillance","volume":"18","author":"Schlumbrecht","year":"2018","journal-title":"BMC Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822018285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822018285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:04:02Z","timestamp":1758773042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825822018285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0090825822018285"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.09.014","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The contemporary presentation and diagnosis of endometrial cancer recurrence: When, where, and how?","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}